fbpx Skip to main content

WEDNESDAY, Dec. 2, 2020 (HealthDay News) — About half of patients with type 2 diabetes mellitus (T2DM) have a very high risk for fatal cardiovascular (CV) events, according to a research letter published online Nov. 13 in the European Journal of Preventive Cardiology.

Ana M. Cebrián-Cuenca, M.D., Ph.D., from the Servicio Murciano de Salud in Cartagena, Spain, and colleagues conducted a cross-sectional study using data for 373,185 patients with T2DM to classify CV risk. Patients were classified in risk categories according to recent guidelines.

The researchers found that for many patients with T2DM, the risk for fatal CV events was very high (53.4 percent). This observation was more pronounced for men than women (55.6 versus 50.7 percent). A large proportion (55.9 percent) of women with T2DM at very high risk did not show established cardiovascular disease (CVD). Prior CVD was seen in about one in four patients with T2DM (26.7 percent). Most patients (92.95 percent) had a high or very high risk for fatal CV events; more than one-third of those T2DM patients without established CVD had very high CV risk (36.4 percent) and should be considered “coronary artery disease”-equivalent patients.

“The most striking result of our study was that the vast majority of patients (93 percent) had a high or very high risk of fatal events within a decade,” a coauthor said in a statement. “Half of patients in the very high-risk group had no history of heart disease, meaning they would not be receiving medications to prevent heart attacks and strokes.”

Abstract/Full Text

You May Also Like::  Systemic Inflammatory Disease Tied to Mortality After MI in Young Adults

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More